Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Teva again raises guidance as branded drugs lift revenue

Revenue in the third quarter was $4.4 billion, while analysts had predicted $4.2 billion and non-GAAP earnings per share was $0.86, well above the analysts’ consensus of $0.72.

Teva again raises guidance as branded drugs lift revenue

We haven't written up this one. Globes English has the full story — the link below goes straight to it.

Read the original at en.globes.co.il →

More in Finance & Markets

CAC 40 Weak Amidst Tech Fears

(RTTNews) - The CAC 40 index that tracks the 40 largest French stocks based on the Euronext Paris slipped on Tuesday as markets focused on the U.S.

More from Tuesday 3 November →